Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Factors XI and XII as Targets for New Anticoagulants.

Weitz JI, Fredenburgh JC.

Front Med (Lausanne). 2017 Feb 24;4:19. doi: 10.3389/fmed.2017.00019. eCollection 2017. Review.

2.

Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells.

Göbel K, Pankratz S, Asaridou CM, Herrmann AM, Bittner S, Merker M, Ruck T, Glumm S, Langhauser F, Kraft P, Krug TF, Breuer J, Herold M, Gross CC, Beckmann D, Korb-Pap A, Schuhmann MK, Kuerten S, Mitroulis I, Ruppert C, Nolte MW, Panousis C, Klotz L, Kehrel B, Korn T, Langer HF, Pap T, Nieswandt B, Wiendl H, Chavakis T, Kleinschnitz C, Meuth SG.

Nat Commun. 2016 May 18;7:11626. doi: 10.1038/ncomms11626.

3.

The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.

Krupka J, May F, Weimer T, Pragst I, Kleinschnitz C, Stoll G, Panousis C, Dickneite G, Nolte MW.

PLoS One. 2016 Jan 27;11(1):e0146783. doi: 10.1371/journal.pone.0146783. eCollection 2016.

4.

New Infestin-4 Mutants with Increased Selectivity against Factor XIIa.

Kolyadko VN, Lushchekina SV, Vuimo TA, Surov SS, Ovsepyan RA, Korneeva VA, Vorobiev II, Orlova NA, Minakhin L, Kuznedelov K, Severinov KV, Ataullakhanov FI, Panteleev MA.

PLoS One. 2015 Dec 15;10(12):e0144940. doi: 10.1371/journal.pone.0144940. eCollection 2015.

5.

Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction.

Long YM, Zhao XC, Clermont AC, Zhou QF, Liu Q, Feener EP, Yan B, Jiang GB.

Nanotoxicology. 2016;10(4):501-11. doi: 10.3109/17435390.2015.1088589. Epub 2015 Sep 23.

6.

Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.

Björkqvist J, de Maat S, Lewandrowski U, Di Gennaro A, Oschatz C, Schönig K, Nöthen MM, Drouet C, Braley H, Nolte MW, Sickmann A, Panousis C, Maas C, Renné T.

J Clin Invest. 2015 Aug 3;125(8):3132-46. doi: 10.1172/JCI77139. Epub 2015 Jul 20.

7.

Inhibition of thrombin generation in human plasma by phospholipid transfer protein.

Deguchi H, Wolfbauer G, Cheung MC, Banerjee Y, Elias DJ, Fernández JA, Albers JJ, Griffin JH.

Thromb J. 2015 Jul 16;13:24. doi: 10.1186/s12959-015-0054-0. eCollection 2015.

8.

Contact pathway of coagulation and inflammation.

Wu Y.

Thromb J. 2015 May 6;13:17. doi: 10.1186/s12959-015-0048-y. eCollection 2015.

9.

Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.

Busardò FP, Frati P, Zaami S, Fineschi V.

Int J Mol Sci. 2015 Mar 23;16(3):6557-70. doi: 10.3390/ijms16036557. Review.

10.

Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway.

Chen JW, Figueiredo JL, Wojtkiewicz GR, Siegel C, Iwamoto Y, Kim DE, Nolte MW, Dickneite G, Weissleder R, Nahrendorf M.

JACC Cardiovasc Imaging. 2012 Nov;5(11):1127-38. doi: 10.1016/j.jcmg.2012.01.025.

11.

In vivo roles of factor XII.

Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C.

Blood. 2012 Nov 22;120(22):4296-303. doi: 10.1182/blood-2012-07-292094. Epub 2012 Sep 19. Review.

12.

Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.

Tucker EI, Verbout NG, Leung PY, Hurst S, McCarty OJ, Gailani D, Gruber A.

Blood. 2012 May 17;119(20):4762-8. doi: 10.1182/blood-2011-10-386185. Epub 2012 Mar 22.

13.

Coagulation procofactor activation by factor XIa.

Whelihan MF, Orfeo T, Gissel MT, Mann KG.

J Thromb Haemost. 2010 Jul;8(7):1532-9. doi: 10.1111/j.1538-7836.2010.03899.x. Epub 2010 May 4.

14.

Hageman factor, platelets and polyphosphates: early history and recent connection.

Caen J, Wu Q.

J Thromb Haemost. 2010 Aug;8(8):1670-4. doi: 10.1111/j.1538-7836.2010.03893.x. Epub 2010 Apr 30. Review.

15.

Transforming growth factor-β1 induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts.

Jablonska E, Markart P, Zakrzewicz D, Preissner KT, Wygrecka M.

J Biol Chem. 2010 Apr 9;285(15):11638-51. doi: 10.1074/jbc.M109.045963. Epub 2010 Feb 8.

16.

Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.

Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T.

Cell. 2009 Dec 11;139(6):1143-56. doi: 10.1016/j.cell.2009.11.001.

17.

Surface-energy dependent contact activation of blood factor XII.

Golas A, Parhi P, Dimachkie ZO, Siedlecki CA, Vogler EA.

Biomaterials. 2010 Feb;31(6):1068-79. doi: 10.1016/j.biomaterials.2009.10.039. Epub 2009 Nov 4.

18.

Contact activation of blood-plasma coagulation.

Vogler EA, Siedlecki CA.

Biomaterials. 2009 Apr;30(10):1857-69. doi: 10.1016/j.biomaterials.2008.12.041. Epub 2009 Jan 24. Review.

Supplemental Content

Support Center